While non-steroidal MRAs have not yet been investigated in type 1 diabetes, based on their observed benefits in type 2 diabetes and their mechanism of action, similar kidney-protective effects are anticipated, emphasising the need for dedicated studies with finerenone in people with type 1 diabetes and CKD, including their use in combination with other repurposed therapies such as SGLT2i and GLP1-RAs
Starting retatrutide at 1 to 2 mg is reasonable
Easy to use Super love it ,i have lost 44 lbs no problems or side effects Service is always GREAT with VITAstir
In this mini-review, we highlight past and present progress in the translational research of GLP-1 and glucagon co-agonism
Most see pills as more natural and less stressful than injections
Taking your injection on a regular schedule allows your body to maintain steady medication levels, which maximizes weight loss results and reduces hunger signals